Skip to content

Construction of a multi-dimensional digitalized diagnosis and treatment system for postoperative somatic-emotional-cognitive cervical spondylotic myelopathy (Phase I) — The effects of cognitive digital therapy on postoperative cognition and clinical evaluation of postoperative cervical spondylotic myelopathy: A single-center randomized controlled clinical trial (preliminary trial)

Construction of a multi-dimensional digitalized diagnosis and treatment system for postoperative somatic-emotional-cognitive cervical spondylotic myelopathy (Phase I) — The effects of cognitive digital therapy on postoperative cognition and clinical evaluation of postoperative cervical spondylotic myelopathy: A single-center randomized controlled clinical trial (preliminary trial)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107675
Enrollment
Unknown
Registered
2025-08-17
Start date
2025-08-17
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

Traditional therapy group:Traditional therapy
Cognitive digital therapy group:Cognitive digital therapy

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 and above, under 80 years old; 6 or more years of education; 2.Patients with cervical spondylotic myelopathy planning surgery (DCM patients who have not responded to conservative treatment for more than 3 months); 3.Agree to participate in this study, follow the randomized allocation scheme to receive either cognitive digital therapy or conventional medical care, and sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Unable to complete cognitive function testing due to vision, hearing, or aphasia problems; 2.Previously diagnosed with dementia or Mini-Mental State Examination (MMSE) score = 20 or GAD-7 score >= 15); 9.Surgical complications (such as nerve damage and dural damage) that affect the patient's ability to participate in cognitive digital therapy; 10.The researcher deems the patient unsuitable for trial participation;

Design outcomes

Primary

MeasureTime frame
Improvement rate of cognitive function;

Secondary

MeasureTime frame
Changes in cervical spine clinical outcome indicators and quality of life;Improvement rate of MoCA score;

Countries

China

Contacts

Public ContactHe Da

Beijing Jishuitan Hospital

hedamd@vip.163.com+86 10 58516959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026